Back to Journals » Clinical Ophthalmology » Volume 13

Clinical Trial Report

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease

       
Total article views   HTML views PDF downloads Totals
11,479 Dovepress* 8,994+ 2,102 11,096
PubMed Central* 2,485 357 2,842
Totals 11,479 2,459 13,938
*Since 12 February 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar